<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00577213</url>
  </required_header>
  <id_info>
    <org_study_id>47573</org_study_id>
    <secondary_id>Chancellor's Fund</secondary_id>
    <nct_id>NCT00577213</nct_id>
  </id_info>
  <brief_title>Diagnosis of Hemangiomas and Vascular Malformations</brief_title>
  <official_title>Diagnosis of Hemangiomas and Vascular Malformations Using Non-invasive Imaging Devices</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Arkansas</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Arkansas</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To develop a non-invasive, simple and affordable, measurement technique to differentiate
      hemangiomas from subtypes of VMS. The purpose of this study is to determine the best office
      based diagnositc instrument for differentiating the subtype of vascular lesions. The
      instrument must be simple and affordable so it can be used by primary car physicians in the
      doctor office. The procedure will be based on non-invasive and unharmful measurements that
      will be compared to the diagnosis from specialized physicians in this field and the final
      pathology.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2007</start_date>
  <completion_date type="Actual">October 2012</completion_date>
  <primary_completion_date type="Actual">October 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <enrollment type="Actual">56</enrollment>
  <condition>Hemangiomas</condition>
  <condition>Vascular Malformations</condition>
  <condition>Venular Malformations</condition>
  <condition>Venous Malformations</condition>
  <condition>Lymphatic Malformations</condition>
  <condition>Arteriovenous Malformations</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Subjects with vascular lesions from the patient populations at Arkansas Children's Hospital
        (ACH) and the University of Arkansas for Medical Sciences (UAMS) will be recruited for the
        study. Approximately 45 subjects from Arkansas Children's Hospital and approximately 10
        subjects from the University of Arkansas for Medical Sciences will be recruited for a total
        of 55.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Suspected Hemangioma, Vascular Malformations (VMS) including venular Malformations
             (port-wine stain, PWS), Venous Malformations, Lymphatic Malformations, Arteriovenous
             Malformations or mixed malformations.

        Exclusion Criteria:

          -  All pregnant individuals will be excluded, since physiologic changes of pregnancy
             could alter characteristics of the vascular lesion.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gal Shafirstein, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>UAMS, ACH, Central Arkansas Veterans Healthcare System</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jessica L Boswell</last_name>
    <role>Study Director</role>
    <affiliation>UAMS, ACH, Central Arkansas Veterans Healthcare System</affiliation>
  </overall_official>
  <verification_date>October 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 18, 2007</study_first_submitted>
  <study_first_submitted_qc>December 18, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 20, 2007</study_first_posted>
  <last_update_submitted>October 25, 2012</last_update_submitted>
  <last_update_submitted_qc>October 25, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 26, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Diagnosis</keyword>
  <keyword>Hemangiomas</keyword>
  <keyword>Vascular Malformations</keyword>
  <keyword>Venular Malformations</keyword>
  <keyword>Venous Malformations</keyword>
  <keyword>Lymphatic Malformations</keyword>
  <keyword>Arteriovenous Malformations</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Congenital Abnormalities</mesh_term>
    <mesh_term>Hemangioma</mesh_term>
    <mesh_term>Arteriovenous Malformations</mesh_term>
    <mesh_term>Vascular Malformations</mesh_term>
    <mesh_term>Lymphangioma</mesh_term>
    <mesh_term>Lymphatic Abnormalities</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

